Spots Global Cancer Trial Database for irofulven
Every month we try and update this database with for irofulven cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Irofulven in Treating Patients With Stage IV Melanoma | NCT00005968 | Melanoma (Skin) | irofulven | 18 Years - | University of Colorado, Denver | |
| 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia | NCT00003997 | Leukemia Myelodysplastic... | irofulven | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors | NCT00012038 | Brain and Centr... | irofulven | 18 Years - | National Cancer Institute (NCI) | |
| Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®) | NCT03643107 | Metastatic Cast... | Irofulven Prednisolone 10... | 18 Years - | Allarity Therapeutics | |
| Irofulven in Treating Patients With Metastatic Breast Cancer | NCT00003796 | Breast Cancer | irofulven | - | National Cancer Institute (NCI) | |
| Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer | NCT00005031 | Endometrial Can... | irofulven | 18 Years - | GOG Foundation | |
| Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors | NCT00012038 | Brain and Centr... | irofulven | 18 Years - | National Cancer Institute (NCI) | |
| Study of Irofulven in Patients With Hormone-refractory Prostate Cancer | NCT00124566 | Prostate Cancer | Irofulven Prednisone Mitoxantrone Capecitabine Irofulven | 18 Years - | Eisai Inc. | |
| Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors | NCT00012038 | Brain and Centr... | irofulven | 18 Years - | National Cancer Institute (NCI) | |
| Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT00019552 | Fallopian Tube ... Ovarian Cancer Primary Periton... | irofulven | 18 Years - | National Cancer Institute (NCI) | |
| Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | NCT00003370 | Unspecified Chi... | irofulven | - 21 Years | National Cancer Institute (NCI) | |
| Irofulven in Treating Patients With Metastatic Breast Cancer | NCT00003796 | Breast Cancer | irofulven | - | National Cancer Institute (NCI) | |
| Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | NCT00003370 | Unspecified Chi... | irofulven | - 21 Years | National Cancer Institute (NCI) | |
| Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer | NCT00003760 | Pancreatic Canc... | irofulven | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer | NCT00053365 | Primary Periton... Recurrent Ovari... | irofulven | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | NCT00062257 | Gastric Cancer | irofulven | 18 Years - | National Cancer Institute (NCI) | |
| Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | NCT00033735 | Pancreatic Canc... | fluorouracil Irofulven | 18 Years - | Eisai Inc. | |
| Irofulven in Treating Patients With Stage IV Melanoma | NCT00005968 | Melanoma (Skin) | irofulven | 18 Years - | University of Colorado, Denver | |
| Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer | NCT00005070 | Cervical Cancer | irofulven | - | Memorial Sloan Kettering Cancer Center | |
| Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | NCT00033735 | Pancreatic Canc... | fluorouracil Irofulven | 18 Years - | Eisai Inc. | |
| Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors | NCT00374660 | Liver Cancer | Oxaliplatin Irofulven | 18 Years - | Eisai Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
